Old Web
English
Sign In
Acemap
>
authorDetail
>
Katherine J. Cato
Katherine J. Cato
Endocrinology
Internal medicine
Biology
Receptor
Antagonist
2
Papers
63
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.
2008
Neuropsychopharmacology
Lee A. Dawson
Katherine J. Cato
Claire M. Scott
Jeannette M. Watson
Martyn D. Wood
Richard R. Foxton
Raúl de la Flor
Gareth A. Jones
James N.C. Kew
Jane E. Cluderay
Eric Southam
Graham Murkitt
Jane Gartlon
Darrel J. Pemberton
Declan N.C. Jones
Ceri H. Davies
Jim J. Hagan
Show All
Source
Cite
Save
Citations (35)
Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade
2006
Cns & Neurological Disorders-drug Targets
Martyn D. Wood
Claire M. Scott
Kirsten Clarke
Katherine J. Cato
Nisha Patel
Jennie Heath
Angela Worby
Laurie J. Gordon
Lorraine Campbell
Graham J. Riley
Ceri H. Davies
Andrew Derrick GlaxoSmithKline Gribble
Declan N.C. Jones
Show All
Source
Cite
Save
Citations (28)
1